OC
GCVRZ

Oakworth Capital’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Oakworth Capital’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,000
Closed – – 674
2017
Q1 		$0 Hold
1,000
– – ﹤0.01% 698
2016
Q4 		$0 Hold
1,000
– – ﹤0.01% 696
2016
Q3 		$0 Hold
1,000
– – ﹤0.01% 699
2016
Q2 		$0 Hold
1,000
– – ﹤0.01% 654
2016
Q1 		$0 Hold
1,000
– – ﹤0.01% 613
2015
Q4 		$0 Hold
1,000
– – ﹤0.01% 597
2015
Q3 		$0 Hold
1,000
– – ﹤0.01% 512
2015
Q2 		$0 Hold
1,000
– – ﹤0.01% 592
2015
Q1 		$1K Hold
1,000
– – ﹤0.01% 483
2014
Q4 		$1K Buy
+1,000
New +$683 ﹤0.01% 474

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Oakworth Capital's GCVRZ Position: Q2 2017 in Review

Oakworth Capital sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2017, closing a stake of 1,000 shares.

Oakworth Capital first reported a position in GCVRZ in Q4 2014 and held it in 10 quarters. The position peaked at $1K in Q1 2015. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2017.

  • Oakworth Capital reported no remaining Sanofi Contingent Value Rights position as of Q2 2017 after selling out during the quarter.
  • Oakworth Capital sold 1,000 Sanofi Contingent Value Rights shares in Q2 2017.
  • Oakworth Capital first reported a position in Sanofi Contingent Value Rights in Q4 2014 and held it in 10 quarters.
  • Oakworth Capital's Sanofi Contingent Value Rights position peaked at $1K in Q1 2015.
  • 115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2017.

Based on Oakworth Capital's 13F filing for Q2 2017, filed 31 Jul 2017.